Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Group Design02:01

Group Design

10.4K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.4K
Factorial Design02:01

Factorial Design

13.8K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.8K
Potential Energy00:52

Potential Energy

42.7K
The energy stored by a structure and location of matter in space is called potential energy. For instance, raising a kettlebell changes its spatial location and increases its potential energy. Similarly, a stretched rubber band contains potential energy which, under certain conditions, can be converted into other forms of energy, such as kinetic energy.
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
42.7K
Subviral Agents01:29

Subviral Agents

556
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
556
Design Example: Creating a Hydraulic Model of a Dam Spillway01:21

Design Example: Creating a Hydraulic Model of a Dam Spillway

728
Scaled hydraulic models of dam spillways provide a practical way to replicate and study the intricate flow dynamics of these structures. Often built to a 1:15 ratio, these models allow for observing critical water behavior, such as velocity distribution, flow patterns, and energy dissipation.
728
Design Example: Designing a Residential Plumbing System01:25

Design Example: Designing a Residential Plumbing System

1.1K
The design of residential plumbing systems requires carefully evaluating water demand, flow rates, and pressure dynamics to ensure both efficiency and reliability. The nature of water flow within pipes is defined by its Reynolds number, which classifies flow as either laminar (smooth) or turbulent.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Therapeutic inhibition of telomeric DNA damage response rescues hematopoietic dysfunction driven by telomere shortening and aging.

Nature aging·2026
Same author

The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group.

Frontiers in oncology·2026
Same author

Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial.

Gynecologic oncology·2026
Same author

Bellerophon: An Automated Tool for PROTAC Decomposition.

ACS medicinal chemistry letters·2026
Same author

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Cell reports·2026

Related Experiment Video

Updated: Jan 28, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.

Andrea Costamagna1, Matteo Rossi Sebastiano2, Dora Natalini1

  • 1Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.

Scientific Reports
|March 1, 2019
PubMed
Summary

Researchers identified a new therapeutic strategy for ErbB2-positive breast cancer by targeting the p130Cas/ErbB2 interaction. Inhibiting this protein-protein interaction (PPI) with novel compounds reduced cancer cell proliferation and improved sensitivity to Trastuzumab.

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.3K

Related Experiment Videos

Last Updated: Jan 28, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • ErbB2 receptor tyrosine kinase overexpression in breast cancer correlates with aggressive disease and poor prognosis.
  • p130Cas scaffold protein overexpression is linked to poor prognosis and metastasis in ErbB2-positive breast cancer.
  • p130Cas association with ErbB2 enhances tumorigenesis by protecting ErbB2 from degradation.

Purpose of the Study:

  • To investigate the direct binding of p130Cas to ErbB2.
  • To identify and validate inhibitors of the p130Cas/ErbB2 interaction.
  • To explore the therapeutic potential of targeting this protein-protein interaction (PPI) in breast cancer.

Main Methods:

  • Molecular Modeling and Molecular Dynamics simulations.
  • Biochemical assays including dot blot, ELISA, and fluorescence quenching.
  • Structure-based virtual screening and in vitro/cellular validation of identified inhibitors.

Main Results:

  • Confirmed direct binding between p130Cas and ErbB2.
  • Identified two compounds that inhibit p130Cas/ErbB2 interaction.
  • Demonstrated that these compounds reduce proliferation and enhance Trastuzumab sensitivity in ErbB2-positive breast cancer cells.

Conclusions:

  • The p130Cas/ErbB2 complex is a viable therapeutic target in breast cancer.
  • Inhibiting this PPI offers a novel strategy for breast cancer treatment.
  • This study opens new avenues for targeting protein-protein interactions (PPIs) in cancer therapy.